Clindamycin Hydrochloride NDC 71335-2623

Product information

Brand name (proprietary)

Clindamycin Hydrochloride

Generic name (nonproprietary)

clindamycin hydrochloride

Active ingredients

Clindamycin hydrochloride — 150 mg/1

Dosage form

Capsule

Route

Oral

Labeler

Bryant Ranch Prepack

Product type

Prescription drug

Marketing category

ANDA — Abbreviated New Drug Application (generic)Application ANDA 216957

Marketing start

Mar 10, 2023

Listing expires

Dec 31, 2027

Other FDA classes

Decreased Sebaceous Gland Activity (Physiologic effect)Lincosamides (Chemical structure)Neuromuscular Blockade (Physiologic effect)

Identifiers

Product ID 71335-2623_6717d1aa-fd69-427d-b0d5-9b9b1ed2e311SPL ID 6717d1aa-fd69-427d-b0d5-9b9b1ed2e311SPL set ID 47f76d99-2024-4531-a527-66c80deeeb37RxCUI 197518UNII T20OQ1YN1W

Pharmacologic class

Lincosamide Antibacterial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N471335262300 followed by a unit qualifier and the quantity Copy

Package 71335-2623-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Other NDCs under ANDA 216957

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

Showing 20 of 23.